Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Cannabis company C21 Investments Inc. (CSE:CXXI) (OTCQX: CXXIF) has qualified to begin trading on the OTCQX, under the symbol CXXIF.
OTC Markets Group Inc. (OTCQX: OTCM) confirmed the news Monday.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Previously, New York-based C21 traded on the OTCQB Venture Market.
"Graduating to the OTCQX Best Markets aligns well with our focus to both improve access and increase the visibility of C21 to a broader base of U.S. investors," said C21 president and CEO Sonny Newman.
Dorsey & Whitney LLP acted as C21's OTCQX sponsor.
"This achievement is a testament to the hard work of our entire team, and we look forward to continuing to execute our strategy of building upon our cash flow positive business," added Newman.
The debut on the OTCQX comes on the heels of its second-quarter earnings report.
C21 reported its cash flow from operations increased by 200% over the quarter to $4.2 million.
Newman noted that they "achieved a critical milestone this quarter."
Meantime, several C21's peers in the industry ended up trading on the OTCQX recently, including Item 9 Labs Corp. (OTCQX: INLB) and Harborside Inc. (CSE:HBOR) (OTCQX: HSDEF).
Courtesy image
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.